Eli Lilly offers AI models to biotechs with TuneLab launchnews2025-09-09T11:00:16+00:00September 9th, 2025|Endpoints News|
Ridge Bio raises $25M to help drugmakers come up with better ADCsnews2025-09-09T10:00:04+00:00September 9th, 2025|Endpoints News|
LB Pharma seeks $228M in proposed IPO with hopes to be industry’s first since Februarynews2025-09-08T14:58:58+00:00September 8th, 2025|Endpoints News|
Biotech vet Harvey Berger steps into CEO role at Arena BioWorksnews2025-09-08T11:00:33+00:00September 8th, 2025|Endpoints News|
Mitochondrial startup gets £50M to test lead drug in ALS, Parkinson’snews2025-09-08T07:00:40+00:00September 8th, 2025|Endpoints News|
Servier buys Medicxi startup’s fragile X candidate for up to $450Mnews2025-09-08T06:30:05+00:00September 8th, 2025|Endpoints News|
China biotech Epigenic raises $60M to test CRISPR epigenetic therapiesnews2025-09-08T02:00:04+00:00September 8th, 2025|Endpoints News|
Hengrui does another US deal, this time in Cytokinetics’ cardio arenanews2025-09-05T08:01:47+00:00September 5th, 2025|Endpoints News|
Atlas Venture raises $400M to support existing portfolio biotechsnews2025-09-04T12:20:23+00:00September 4th, 2025|Endpoints News|
Enveda collects another $150M for I&I drug, sprawling pipeline of preclinical assetsnews2025-09-04T12:00:55+00:00September 4th, 2025|Endpoints News|
